APA (7th ed.) Citation

Chung, Y., Lam, D., Mainguy, A., Fardeau, C., Couret, C., Weber, M., . . . Touhami, S. (2025). Long-Term Effects of Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 3- and 6-Year Results of the ADJUVITE Trial. Ocular Immunology & Inflammation, 33(10), 2265. https://doi.org/10.1080/09273948.2025.2495826

Chicago Style (17th ed.) Citation

Chung, Yoo-Ri, et al. "Long-Term Effects of Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 3- and 6-Year Results of the ADJUVITE Trial." Ocular Immunology & Inflammation 33, no. 10 (2025): 2265. https://doi.org/10.1080/09273948.2025.2495826.

MLA (9th ed.) Citation

Chung, Yoo-Ri, et al. "Long-Term Effects of Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 3- and 6-Year Results of the ADJUVITE Trial." Ocular Immunology & Inflammation, vol. 33, no. 10, 2025, p. 2265, https://doi.org/10.1080/09273948.2025.2495826.